Sex differences in cognitive impairment and Alzheimer's disease

被引:356
|
作者
Li, Rena [1 ]
Singh, Meharvan [2 ]
机构
[1] Roskamp Inst, Ctr Hormone Adv Sci & Educ, Sarasota, FL 34243 USA
[2] Univ N Texas, Hlth Sci Ctr, Ctr FOR HER, Dept Pharmacol & Neurosci,Inst Aging & Alzheimers, Ft Worth, TX 76107 USA
基金
美国国家卫生研究院;
关键词
Gender; Sex difference; Steroid hormones; Cognition; Alzheimer's disease; ESTROGEN-REPLACEMENT THERAPY; ACTIVATED PROTEIN-KINASE; CONJUGATED EQUINE ESTROGENS; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; MENTAL ROTATION PERFORMANCE; THROMBOSPONDIN-4 A387P POLYMORPHISM; NATIONAL COMORBIDITY SURVEY; HEALTH INITIATIVE MEMORY; BETA-ESTRADIOL PROTECTS;
D O I
10.1016/j.yfrne.2014.01.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies have shown differences in specific cognitive ability domains and risk of Alzheimer's disease between the men and women at later age. However it is important to know that sex differences in cognitive function during adulthood may have their basis in both organizational effects, i.e., occurring as early as during the neuronal development period, as well as in activational effects, where the influence of the sex steroids influence brain function in adulthood. Further, the rate of cognitive decline with aging is also different between the sexes. Understanding the biology of sex differences in cognitive function will not only provide insight into Alzheimer's disease prevention, but also is integral to the development of personalized, gender-specific medicine. This review draws on epidemiological, translational, clinical, and basic science studies to assess the impact of sex differences in cognitive function from young to old, and examines the effects of sex hormone treatments on Alzheimer's disease in men and women. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:385 / 403
页数:19
相关论文
共 50 条
  • [31] Mechanisms of sex differences in Alzheimer's disease
    Lopez-Lee, Chloe
    Torres, Eileen Ruth S.
    Carling, Gillian
    Gan, Li
    [J]. NEURON, 2024, 112 (08) : 1208 - 1221
  • [32] Sex differences in risk factors that predict progression from mild cognitive impairment to Alzheimer's dementia
    Berezuk, Courtney
    Khan, Maleeha
    Callahan, Brandy L.
    Ramirez, Joel
    Black, Sandra E.
    Zakzanis, Konstantine K.
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2023, 29 (04) : 360 - 368
  • [33] Cognitive impairment in patients with Alzheimer's disease and Parkinson's disease
    Chyniak, O.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S289 - S289
  • [34] Sex and gender differences in cognitive and brain reserve: Implications for Alzheimer's disease in women
    Subramaniapillai, Sivaniya
    Almey, Anne
    Rajah, M. Natasha
    Einstein, Gillian
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 2021, 60
  • [35] Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment
    Lindeboom, J
    Weinstein, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) : 83 - 86
  • [36] Mild cognitive impairment: Aging to Alzheimer's disease
    Heilbronner, RL
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (05) : 718 - 722
  • [37] FMRI in mild cognitive impairment and Alzheimer's disease
    Rombouts, S
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S49 - S49
  • [38] Galantamine for Alzheimer's disease and mild cognitive impairment
    Cusi, Cristina
    Cantisani, Teresa Anna
    Celani, Maria Grazia
    Incorvaia, Barbara
    Righetti, Enrico
    Candelise, Livia
    [J]. NEUROEPIDEMIOLOGY, 2007, 28 (02) : 116 - 117
  • [39] Network substrates of cognitive impairment in Alzheimer's Disease
    Tait, Luke
    Stothar, George
    Coulthard, Elizabeth
    Brown, Jon T.
    Kazanina, Nina
    Goodfellow, Marc
    [J]. CLINICAL NEUROPHYSIOLOGY, 2019, 130 (09) : 1581 - 1595
  • [40] Mild cognitive impairment and preclinical Alzheimer's disease
    Morris, JC
    [J]. GERIATRICS-US, 2005, : 9 - 14